Comparison of the renal, cardiovascular and hepatic toxicity data of original intravenous iron compounds.
about
Iron therapy for the treatment of iron deficiency in chronic heart failure: intravenous or oral?Optimizing iron delivery in the management of anemia: patient considerations and the role of ferric carboxymaltose.Effect of intravenous iron use on hospitalizations in patients undergoing hemodialysis: a comparative effectiveness analysis from the DEcIDE-ESRD study.Ferrous sulfate, but not iron polymaltose complex, aggravates local and systemic inflammation and oxidative stress in dextran sodium sulfate-induced colitis in rats.Comparison of oxidative stress and inflammation induced by different intravenous iron sucrose similar preparations in a rat modelRenal function in patients with non-dialysis chronic kidney disease receiving intravenous ferric carboxymaltose: an analysis of the randomized FIND-CKD trialThe Induction of Oxidative/Nitrosative Stress, Inflammation, and Apoptosis by a Ferric Carboxymaltose Copy Compared to Iron Sucrose in a Non-Clinical Model.The iron cycle in chronic kidney disease (CKD): from genetics and experimental models to CKD patients.Current management of iron deficiency anemia in inflammatory bowel diseases: a practical guide.Ferric carboxymaltose: a review of its use in iron deficiency.Effects of iron supplementation on erythropoietic response in patients with cancer-associated anemia treated by means of erythropoietic stimulating agents.Controversial issues in CKD clinical practice: position statement of the CKD-treatment working group of the Italian Society of Nephrology.Bioavailability and stability of intravenous iron sucrose originator versus generic iron sucrose AZAD.Ferric carboxymaltose-mediated attenuation of Doxorubicin-induced cardiotoxicity in an iron deficiency rat model.Differences in activation of mouse hepcidin by dietary iron and parenterally administered iron dextran: compartmentalization is critical for iron sensing.Nitrosative stress and apoptosis in non-anemic healthy rats induced by intravenous iron sucrose similars versus iron sucrose originator.Cardiovascular, liver, and renal toxicity associated with an intravenous ferric carboxymaltose similar versus the originator compound.Non-transferrin bound iron, cytokine activation and intracellular reactive oxygen species generation in hemodialysis patients receiving intravenous iron dextran or iron sucrose.
P2860
Q28088503-FD601796-DEEB-422E-A0D0-495A9050200FQ34700903-AF11E8BD-529A-40A2-BA6E-A067E51632F1Q35474305-A9004447-F746-461C-A666-EE256D5CEE55Q35596454-1483FE63-AE04-4488-AE9C-75CD98CEA390Q35931905-A4108477-068E-4634-93F2-BDDF66F9027DQ36251928-95558C53-5D99-486D-93CC-543F3E7AE780Q36476581-41E1F61A-C737-4055-BA4E-0FE83F2385DEQ37542851-6D5E6C79-37D6-44C7-894F-919E9E5CB4C4Q38151564-7016128C-DBCB-48E0-9537-72FFD89CEB03Q38271890-058E1920-2551-490B-B508-6825C0911888Q38755414-38F3487D-FFB1-46C8-849B-358470740FCAQ38939078-932313A0-2625-4C3C-8559-0B40251C273DQ39317065-A8163B58-D624-4B16-B214-F66A0A6BE859Q39642839-2E5AC7C4-F1BA-48ED-AE42-E14833682E5FQ44320542-5D7EAF4A-9DAA-440B-84BA-19552555B1E7Q46783918-C4B500BE-1F19-4394-894A-7BFF6F937818Q49300014-50C0108E-3210-4997-BA48-8FD7928DEA25Q51733222-65060B7F-A6ED-4B56-B1D6-B13E8453A304
P2860
Comparison of the renal, cardiovascular and hepatic toxicity data of original intravenous iron compounds.
description
2010 nî lūn-bûn
@nan
2010 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Comparison of the renal, cardi ...... al intravenous iron compounds.
@ast
Comparison of the renal, cardi ...... al intravenous iron compounds.
@en
Comparison of the renal, cardi ...... al intravenous iron compounds.
@nl
type
label
Comparison of the renal, cardi ...... al intravenous iron compounds.
@ast
Comparison of the renal, cardi ...... al intravenous iron compounds.
@en
Comparison of the renal, cardi ...... al intravenous iron compounds.
@nl
prefLabel
Comparison of the renal, cardi ...... al intravenous iron compounds.
@ast
Comparison of the renal, cardi ...... al intravenous iron compounds.
@en
Comparison of the renal, cardi ...... al intravenous iron compounds.
@nl
P2093
P2860
P356
P1476
Comparison of the renal, cardi ...... al intravenous iron compounds.
@en
P2093
Gabriel Cao
Jorge E Toblli
Leda Olivieri
Margarita Angerosa
P2860
P304
P356
10.1093/NDT/GFQ260
P407
P577
2010-05-20T00:00:00Z